Advanced Search

Pathology/Lab Coding Alert

READER QUESTION:

Report New CLIA-Waived HIV Test

Published on Sun Jun 01, 2003

Question: Our lab will begin performing a new test manufactured by OraSure Technologies called OraQuick Rapid HIV-1 Antibody Test. How should we code this test? Illinois Subscriber Answer: The U.S. Food and Drug Administration recently approved this HIV test as a waived test under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). You should report the test using 86701 (Antibody; HIV-1). If you operate as a CLIA-waived status lab, you must report the code with modifier -QW (CLIA-waived test) to indicate that your lab is allowed to perform the test. CMS has issued a National Coverage Determination (NCD) for multi-step HIV-1 immunoassays, so claims for 86701-QW are subject to the NCD coverage restrictions. .
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pathology/Lab Coding Alert

View All